News

All news

2020-05-05

ACCORD HEALTHCARE LAUNCH CINACALCET ACCORD 30 MG, 60 MG & 90 MG TABLETS

Accord Healthcare is delighted to announce the launch of another Hi-Tech medicine to their extensive range of Hi Tech medicines, Cinacalcet Accord 30 mg, 60 mg and 90 mg film-coated tablets in pack size of 28.

This medicine is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet Accord may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. It is also indicated for the reduction of hypercalcaemia in adult patients with parathyroid carcinoma or primary HPT for whom parathyroidectomy would be indicated based on serum calcium levels, but is not clinically appropriate or is contraindicated.

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC will be available from www.hpra.ie and for Healthcare Professionals here

Think Hi Techs, Think Accord

All news